To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic
Closed Special Notice Posted
- Solicitation number
- 75N94024R00034
- Agency
-
National Institute of Child Health and Human Development
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health (NIH), National Institute of Child Health and Human Development (NICHD) has issued a Special Notice to obtain information on the availability and capabilities of qualified small business sources that could provide services for a Biological Testing Facility (BTF) to support the preclinical development of contraceptives, reproductive health, and/or therapeutic products. The BTF is intended to fulfill a unique role in bridging the discovery of contraceptive targets to the development and approval of contraceptive products.
The primary objective of the BTF is to provide a state-of-the-art facility and capabilities to conduct biological safety and efficacy evaluations of new entities to support regulatory requirements for clinical trials. The anticipated contract will be an Indefinite Delivery Indefinite Quantity (IDIQ) type, with a period of performance from 09/03/2025 to 9/2/2032. The NAICS code is 541715 with a size standard of 1,000 employees or less. Capability statements must be submitted by 12:00 PM Eastern Time on November 21, 2024 and will be evaluated on experience, expertise, and capabilities in areas such as preclinical services, formulation, GLP/GMP facilities, project management, and data/inventory management.
Notice text
The Biological Testing Facility (BTF) fulfills a unique role in bridging the discovery of contraceptive targets to the development and approval of the contraceptive products. To this end, the studies at the BTF will encompass discovery and optimization of compounds as anti-fertility agents. In addition, the BTF has an important role in enriching and providing the pre-clinical support services necessary to make progress toward the development of high quality, safe and effective male and female contraceptive products.
Files
| File | Type | Posted |
|---|---|---|
| SOURCES_SOUGHT_SYNOPSIS_BTF_2024_110524_2.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Special Notice | |
| To award Indefinite Delivery Indefinite Quantity (IDIQ) Contract for a Biologic | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity